Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1030436]Researchers: A/Pr Phillip Darcy (Principal investigator)
Brief description White blood cells from cancer patients can be modified in the laboratory to react against tumours. Although these cells can induce cancer regression when given back to the patient, these cells can often cause associated pathology. In this study we propose to fully investigate the limits of this type of therapy for mediating anti-tumour responses and potential toxicity in mouse models that closely recapitulate the human setting. These studies will lead to a more effective therapy for patients.
Funding Amount $AUD 337,614.21
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1030436
- PURL : https://purl.org/au-research/grants/nhmrc/1030436
